24 June 2019
Disposal of Chemring Defence…
21 June 2019
Appointment of Chief Financial Officer…
Trading Update
Completion of formation of a new Joint Venture with BRAVO and acquisition…
20 June 2019
Trading Update and Statement Regarding a Possible Offer…
19 June 2019
Q1 FY20 Trading Update
18 June 2019
Lynparza approved in the EU for 1st-line maintenance treatment of BRCA-mutated advanced ovarian cancer…
17 June 2019
Results for the six months to 30 April 2019…